Luo X, Yuan Q, Li J, Wu J, Zhu B, Lv M
Pneumonia (Nathan). 2025; 17(1):5.
PMID: 39994753
PMC: 11852584.
DOI: 10.1186/s41479-025-00156-0.
Dorji K, Phuntsho S, Pempa , Kumluang S, Khuntha S, Kulpeng W
Vaccine. 2018; 36(13):1757-1765.
PMID: 29478752
PMC: 5858152.
DOI: 10.1016/j.vaccine.2018.02.048.
Lee Y, Huang Y, Kim S, Kerpelev M, Gonzalez V, Kaltsas A
Clin Infect Dis. 2017; 66(2):244-253.
PMID: 29020313
PMC: 5850633.
DOI: 10.1093/cid/cix739.
Fuller J, Eisenberg J
Am J Trop Med Hyg. 2016; 95(5):1201-1210.
PMID: 27601516
PMC: 5094239.
DOI: 10.4269/ajtmh.15-0677.
Haasis M, Ceria J, Kulpeng W, Teerawattananon Y, Alejandria M
PLoS One. 2015; 10(7):e0131156.
PMID: 26131961
PMC: 4488861.
DOI: 10.1371/journal.pone.0131156.
Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population.
Wang M, Wang Y, Chu C, Tu T, Shiao A, Chou P
ScientificWorldJournal. 2015; 2015:248678.
PMID: 25839052
PMC: 4370197.
DOI: 10.1155/2015/248678.
The protective effect of adenoidectomy on pediatric tympanostomy tube re-insertions: a population-based birth cohort study.
Wang M, Wang Y, Chu C, Tu T, Shiao A, Chou P
PLoS One. 2014; 9(7):e101175.
PMID: 24983459
PMC: 4077749.
DOI: 10.1371/journal.pone.0101175.
Epidemiological analysis on two decades of hospitalisations for meningitis in the United States.
Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T
Eur J Clin Microbiol Infect Dis. 2014; 33(9):1519-24.
PMID: 24756210
DOI: 10.1007/s10096-014-2102-2.
Targeting imperfect vaccines against drug-resistance determinants: a strategy for countering the rise of drug resistance.
Joice R, Lipsitch M
PLoS One. 2013; 8(7):e68940.
PMID: 23935910
PMC: 3723804.
DOI: 10.1371/journal.pone.0068940.
Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine.
Kristiansen P, Ky Ba A, Sanou I, Ouedraogo A, Ouedraogo R, Sangare L
BMC Infect Dis. 2013; 13:363.
PMID: 23914778
PMC: 3750508.
DOI: 10.1186/1471-2334-13-363.
Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination.
Munier A, de Lastours V, Varon E, Donay J, Porcher R, Molina J
Infection. 2013; 41(3):663-8.
PMID: 23404685
DOI: 10.1007/s15010-013-0419-x.
Impact of pneumococcal conjugate vaccination on otitis media: a systematic review.
Taylor S, Marchisio P, Vergison A, Harriague J, Hausdorff W, Haggard M
Clin Infect Dis. 2012; 54(12):1765-73.
PMID: 22423134
PMC: 3357481.
DOI: 10.1093/cid/cis292.
Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.
Inoue S, Watanuki Y, Kaneko T, Sato T, Miyazawa N, Kaneko T
BMJ Open. 2011; 1(1):e000105.
PMID: 22021764
PMC: 3191416.
DOI: 10.1136/bmjopen-2011-000105.
Pneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007.
Lucey J, Gavin P, Cafferkey M, Butler K
Ir J Med Sci. 2010; 180(1):47-50.
PMID: 21072618
DOI: 10.1007/s11845-010-0620-1.
Childhood pneumococcal diseases and serotypes: can vaccines protect?.
Hon K, Ip M, Lee K, Nelson E, Shea K, Yuen Y
Indian J Pediatr. 2010; 77(12):1387-91.
PMID: 20844989
DOI: 10.1007/s12098-010-0188-9.
Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota.
Tsigrelis C, Tleyjeh I, Lahr B, Nyre L, Virk A, Baddour L
J Infect. 2009; 59(3):188-93.
PMID: 19635635
PMC: 2743782.
DOI: 10.1016/j.jinf.2009.07.004.
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.
Hsu H, Shutt K, Moore M, Beall B, Bennett N, Craig A
N Engl J Med. 2009; 360(3):244-56.
PMID: 19144940
PMC: 4663990.
DOI: 10.1056/NEJMoa0800836.
Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study.
Tsigrelis C, Tleyjeh I, Lahr B, Nyre L, Virk A, Baddour L
Clin Infect Dis. 2008; 47(11):1367-71.
PMID: 18945210
PMC: 2582965.
DOI: 10.1086/592970.
Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
Kelly D, Moxon E, Yu L, Pollard A
Clin Vaccine Immunol. 2008; 16(2):246-52.
PMID: 18784340
PMC: 2643546.
DOI: 10.1128/CVI.00023-08.
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.
Musher D, Rueda A, Nahm M, Graviss E, Rodriguez-Barradas M
J Infect Dis. 2008; 198(7):1019-27.
PMID: 18710324
PMC: 2631393.
DOI: 10.1086/591629.
